BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Khan S, Cameron S, Blaschke M, Moriconi F, Naz N, Amanzada A, Ramadori G, Malik IA. Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: Role of cytokines. World J Gastroenterol 2014; 20(11): 2979-2994 [PMID: 24659889 DOI: 10.3748/wjg.v20.i11.2979]
URL: https://www.wjgnet.com/1007-9327/full/v20/i11/2979.htm
Number Citing Articles
1
Yiting Zhang, Linjing Xu, Ling Li. The feasibility of using the compound kushen injection to treat cervical cancer based on network pharmacology and transcriptomicsMedicine 2023; 102(36): e35135 doi: 10.1097/MD.0000000000035135
2
Shuyi Cen, Kun Liu, Yu Zheng, Jianzhen Shan, Chao Jing, Jiale Gao, Hongming Pan, Zhigang Bai, Zhen Liu. BRAF Mutation as a Potential Therapeutic Target for Checkpoint Inhibitors: A Comprehensive Analysis of Immune Microenvironment in BRAF Mutated Colon CancerFrontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.705060
3
Yan Zou, Fengxian Qin, Jifei Chen, Jie Meng, Liuhua Wei, Chunlin Wu, Qiaoyun Zhang, Dong Wei, Xiang Chen, Hao Wu, Xiaoli Chen, Shengming Dai. sTLR4/MD-2 complex inhibits colorectal cancer in vitro and in vivo by targeting LPSOncotarget 2016; 7(32): 52032 doi: 10.18632/oncotarget.10496
4
Juan Garona, Marina Pifano, Giselle Ripoll, Daniel F. Alonso. VasopressinVitamins and Hormones 2020; 113: 259 doi: 10.1016/bs.vh.2019.08.010
5
Natalia Kuhn, Bertram Klinger, Florian Uhlitz, Anja Sieber, Maria Rivera, Kathleen Klotz-Noack, Iduna Fichtner, Jens Hoffmann, Nils Blüthgen, Christine Falk, Christine Sers, Reinhold Schäfer. Mutation-specific effects of NRAS oncogenes in colorectal cancer cellsAdvances in Biological Regulation 2021; 79: 100778 doi: 10.1016/j.jbior.2020.100778
6
Jun Zeng, Zhong-Hua Tang, Shuang Liu, Shan-Shan Guo. Clinicopathological significance of overexpression of interleukin-6 in colorectal cancerWorld Journal of Gastroenterology 2017; 23(10): 1780-1786 doi: 10.3748/wjg.v23.i10.1780
7
GUIHUA WANG, JIANFEI HUANG, HUIJUN ZHU, SHAOQING JU, HUIMIN WANG, XUDONG WANG. Overexpression of GRO-β is associated with an unfavorable outcome in colorectal cancerOncology Letters 2016; 11(4): 2391 doi: 10.3892/ol.2016.4222
8
Anjong Florence Tikum, Jessica P. Ketchemen, Alireza Doroudi, Anand K. Nambisan, Hanan Babeker, Fabrice Ngoh Njotu, Humphrey Fonge. Effectiveness of225Ac-Labeled Anti-EGFR Radioimmunoconjugate in EGFR-Positive Kirsten Rat Sarcoma Viral Oncogene and BRAF Mutant Colorectal Cancer ModelsJournal of Nuclear Medicine 2024; 65(3): 402 doi: 10.2967/jnumed.123.266204
9
Nadia Baartzes, Cristina Szabo, Mihai Cenariu, Florica Imre-Lucaci, Sorin Aurel Dorneanu, Eva Fischer-Fodor, Gregory S. Smith. In vitro antitumour activity of two ferrocenyl metallodendrimers in a colon cancer cell lineInorganic Chemistry Communications 2018; 98: 75 doi: 10.1016/j.inoche.2018.09.042
10
Ihtzaz Ahmed Malik, Giuliano Ramadori. Interleukin-6-Production Is Responsible for Induction of Hepatic Synthesis of Several Chemokines as Acute-Phase Mediators in Two Animal Models: Possible Significance for Interpretation of Laboratory Changes in Severely Ill PatientsBiology 2022; 11(3): 470 doi: 10.3390/biology11030470
11
Anne-France le Rolle, Thang K Chiu, Michael Fara, Jinru Shia, Zhaoshi Zeng, Martin R Weiser, Philip B Paty, Vi K Chiu. The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblastsJournal of Translational Medicine 2015; 13(1) doi: 10.1186/s12967-015-0555-4
12
Agnes Ling, Ida V Lundberg, Vincy Eklöf, Maria L Wikberg, Åke Öberg, Sofia Edin, Richard Palmqvist. The infiltration, and prognostic importance, of Th1 lymphocytes vary in molecular subgroups of colorectal cancerThe Journal of Pathology: Clinical Research 2016; 2(1): 21 doi: 10.1002/cjp2.31
13
Xiaoying Ye, King C. Chan, Andrew M. Waters, Matthew Bess, Adam Harned, Bih-Rong Wei, Jadranka Loncarek, Brian T. Luke, Benjamin C. Orsburn, Bradley D. Hollinger, Robert M. Stephens, Rachel Bagni, Alex Martinko, James A. Wells, Dwight V. Nissley, Frank McCormick, Gordon Whiteley, Josip Blonder. Comparative proteomics of a model MCF10A-KRasG12V cell line reveals a distinct molecular signature of the KRasG12V cell surfaceOncotarget 2016; 7(52): 86948 doi: 10.18632/oncotarget.13566
14
Fenghua Zhang, Jingting Jiang, Bin Xu, Yun Xu, Changping Wu. Over-expression of CXCL2 is associated with poor prognosis in patients with ovarian cancerMedicine 2021; 100(4): e24125 doi: 10.1097/MD.0000000000024125
15
Jan Korbecki, Mateusz Bosiacki, Katarzyna Barczak, Ryta Łagocka, Dariusz Chlubek, Irena Baranowska-Bosiacka. The Clinical Significance and Role of CXCL1 Chemokine in Gastrointestinal CancersCells 2023; 12(10): 1406 doi: 10.3390/cells12101406
16
Camille Ternet, Christina Kiel. Signaling pathways in intestinal homeostasis and colorectal cancer: KRAS at centre stageCell Communication and Signaling 2021; 19(1) doi: 10.1186/s12964-021-00712-3
17
Juan Garona, Natasha T. Sobol, Marina Pifano, Valeria I. Segatori, Daniel E. Gomez, Giselle V. Ripoll, Daniel F. Alonso. Preclinical Efficacy of [V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal CancerCancer Research and Treatment 2019; 51(2): 438 doi: 10.4143/crt.2018.040
18
JIATENG ZHONG, JINGYU GUO, XINYU ZHANG, SHUANG FENG, WENYU DI, YANLING WANG, HUIFANG ZHU. The remodeling roles of lipid metabolism in colorectal cancer cells and immune microenvironmentOncology Research 2022; 30(5): 231 doi: 10.32604/or.2022.027900
19
Simona Delle Monache, Alessio Cortellini, Alessandro Parisi, Fanny Pulcini, Stefano Martellucci, Cecilia Mei, Maria Enrica Danubio, Vincenzo Mattei, Adriano Angelucci, Corrado Ficorella. Expression of pro-angiogenic factors as potential biomarkers in experimental models of colon cancerJournal of Cancer Research and Clinical Oncology 2020; 146(6): 1427 doi: 10.1007/s00432-020-03186-x